» Articles » PMID: 12376530

Scavenger Receptors Class A-I/II and CD36 Are the Principal Receptors Responsible for the Uptake of Modified Low Density Lipoprotein Leading to Lipid Loading in Macrophages

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2002 Oct 12
PMID 12376530
Citations 374
Authors
Affiliations
Soon will be listed here.
Abstract

Modification of low density lipoprotein (LDL) can result in the avid uptake of these lipoproteins via a family of macrophage transmembrane proteins referred to as scavenger receptors (SRs). The genetic inactivation of either of two SR family members, SR-A or CD36, has been shown previously to reduce oxidized LDL uptake in vitro and atherosclerotic lesions in mice. Several other SRs are reported to bind modified LDL, but their contribution to macrophage lipid accumulation is uncertain. We generated mice lacking both SR-A and CD36 to determine their combined impact on macrophage lipid uptake and to assess the contribution of other SRs to this process. We show that SR-A and CD36 account for 75-90% of degradation of LDL modified by acetylation or oxidation. Cholesteryl ester derived from modified lipoproteins fails to accumulate in macrophages taken from the double null mice, as assessed by histochemistry and gas chromatography-mass spectrometry. These results demonstrate that SR-A and CD36 are responsible for the preponderance of modified LDL uptake in macrophages and that other scavenger receptors do not compensate for their absence.

Citing Articles

Emerging Gene Therapy Based on Nanocarriers: A Promising Therapeutic Alternative for Cardiovascular Diseases and a Novel Strategy in Valvular Heart Disease.

Yang H, Li J, Song C, Li H, Luo Q, Chen M Int J Mol Sci. 2025; 26(4).

PMID: 40004206 PMC: 11855571. DOI: 10.3390/ijms26041743.


Linking macrophage metabolism to function in the tumor microenvironment.

Jin R, Neufeld L, McGaha T Nat Cancer. 2025; 6(2):239-252.

PMID: 39962208 DOI: 10.1038/s43018-025-00909-2.


Annexin A8 deficiency delays atherosclerosis progression.

Gutierrez-Munoz C, Blazquez-Serra R, San Sebastian-Jaraba I, Sanz-Andrea S, Fernandez-Gomez M, Nunez-Moreno G Clin Transl Med. 2025; 15(1):e70176.

PMID: 39835780 PMC: 11748212. DOI: 10.1002/ctm2.70176.


USP18 Promotes Cholesterol Efflux and Mitigates Atherosclerosis by Deubiquitinating ABCG1.

An Y, Guo C, Wang X, Liu J, Li Z, Ding J J Cell Mol Med. 2025; 29(1):e70320.

PMID: 39804798 PMC: 11728483. DOI: 10.1111/jcmm.70320.


Emerging role of natural killer cells in non-AIDS comorbidities during suppressive antiretroviral therapy.

Alles M, Demberg T, Liyanage N Curr Opin HIV AIDS. 2025; 20(2):145-153.

PMID: 39774039 PMC: 11802316. DOI: 10.1097/COH.0000000000000913.